Your browser doesn't support javascript.
loading
Development of 64Cu-NOTA-Trastuzumab for HER2 Targeting: A Radiopharmaceutical with Improved Pharmacokinetics for Human Studies.
Woo, Sang-Keun; Jang, Su Jin; Seo, Min-Jung; Park, Ju Hui; Kim, Byoung Soo; Kim, Eun Jung; Lee, Yong Jin; Lee, Tae Sup; An, Gwang Il; Song, In Ho; Seo, Youngho; Kim, Kwang Il; Kang, Joo Hyun.
Afiliação
  • Woo SK; Division of RI-Convergence Research, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea; and.
  • Jang SJ; Division of RI-Convergence Research, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea; and.
  • Seo MJ; Division of RI-Convergence Research, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea; and kang2325@kirams.re.kr.
  • Park JH; Division of RI-Convergence Research, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea; and.
  • Kim BS; Division of RI-Convergence Research, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea; and.
  • Kim EJ; Division of RI-Convergence Research, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea; and.
  • Lee YJ; Division of RI-Convergence Research, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea; and.
  • Lee TS; Division of RI-Convergence Research, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea; and.
  • An GI; Division of RI-Convergence Research, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea; and kang2325@kirams.re.kr.
  • Song IH; Division of RI-Convergence Research, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea; and.
  • Seo Y; Department of Radiology, University of California San Francisco School of Medicine, San Francisco, California kang2325@kirams.re.kr.
  • Kim KI; Division of RI-Convergence Research, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea; and.
  • Kang JH; Division of RI-Convergence Research, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea; and kang2325@kirams.re.kr.
J Nucl Med ; 60(1): 26-33, 2019 01.
Article em En | MEDLINE | ID: mdl-29777007
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Radioisótopos de Cobre / Receptor ErbB-2 / Compostos Radiofarmacêuticos / Trastuzumab / Compostos Heterocíclicos com 1 Anel Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Radioisótopos de Cobre / Receptor ErbB-2 / Compostos Radiofarmacêuticos / Trastuzumab / Compostos Heterocíclicos com 1 Anel Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article